Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform

Zheng B., Green ACA., Tazare J., Curtis H., Fisher L., Nab L., Schultze A., Mahalingasivam V., Parker EPK., Hulme W., Bacon SCJ., DeVito N., Bates C., Evans D., Inglesby P., Drysdale H., Davy S., Cockburn J., Morton C., Hickman G., Ward T., Smith R., Parry J., Hester F., Harper S., Mehrkar A., Eggo R., Walker A., Evans SJW., Douglas I., MacKenna B., Goldacre B., Tomlinson L.

DOI

10.1101/2022.05.22.22275417

Type

Preprint

Publication Date

2022

Permalink Original publication